Missing spleen: Indication for pneumococcal vaccination;Geen milt meer: Indicatie voor pneumokokkenvaccinatie

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 10, 2003, Pages 425-428

  Van Dijk, G W ^a   Van Leeuwen, H J ^a   Van Gijn, J ^a   Hoepelman, I M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; CASE REPORT; DEATH; DISABILITY; DISEASE SEVERITY; DRUG INDICATION; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTENSIVE CARE; POSTOPERATIVE INFECTION; SPLEEN INJURY; SPLENECTOMY; VACCINATION;

ADULT; FATAL OUTCOME; FEMALE; HUMANS; MENINGITIS, PNEUMOCOCCAL; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RISK FACTORS; SPLENECTOMY;

EID: 0037426010     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Holdsworth RJ, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991;78:1031-8.
2. Shaw JH, Print CG. Postsplenectomy sepsis. Br J Surg 1989;76:1074-81.
3. Aavitsland P, Froholm LO, Hoiby EA, Lystad A. Risk of pneumococcal disease in individuals without a spleen. Lancet 1994;344:1504.
4. Rijkers GT, Sanders EAM, Breukels MA, Zegers BJM. Infant B-cell responses to polysacharide determinants. Vaccine 1998;16:1396-400.
5. Tamminga RY, Timens W, Kamps WA. Het gevaar van asplenie: een foudroyant verlopende sepsis. Ned Tijdschr Geneeskd 1992;136:257-9.
6. Meer JWM van der. Preventie van foudroyante sepsis na splenectomie. Ned Tijdschr Geneeskd 1992;136:260-1.
7. Visser M, Hogeman PHG, Vught AJ van, Révész T, Wolfs TFW. Fulminant verlopende pneumokokkensepsis bij een 2-jarig kind met sikkelcelanemie. Ned Tijdschr Geneeskd 2003;147:454-6.
8. Gezondheidsraad. Advies inzake Pneumococcen-immunisatie. Publicatienr. 1982/14. Den Haag: Gezondheidsraad; 1982.
9. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. BMJ 1996;312:430-4.
10. American Academy of Pediatrics. Committee on Infectious diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000;106:362-6.
11. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 1993;270:1826-31.
12. Brigden ML, Patullo A, Brown G. Pneumococcal vaccin administration associated with splenectomy: the need for improved education, documentation, and the use of a practical checklist. Am J Hematol 2000;65:25-9.